Multicenter phase 2 study of patupilone for recurrent or progressive brain metastases from non–small cell lung cancer

E-ISSN： 1097-0142|121|23|4165-4172

ISSN： 0008-543X

Source： Cancer, Vol.121, Iss.23, 2015-12, pp. : 4165-4172

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Randomized Phase 2 Study of Radiotherapy Alone Versus Radiotherapy with Paclitaxel in Non-small Cell Lung Cancer

By Sarihan S Kayisogullari U Ercan I Engin K

The Journal of International Medical Research, Vol. 32, Iss. 4, 2004-07 ,pp. : 375-383

Field House Publishing

Access to resources Recommend Favorite

Role of EGFR Inhibitors in the Treatment of Central Nervous System Metastases from Non-Small Cell Lung Cancer

Current Cancer Drug Targets, Vol. 12, Iss. 3, 2012-03 ,pp. : 237-246

Bentham Science Publishers

Access to resources Recommend Favorite

Bone Metastases and Non-Small Cell Lung Cancer: From Bisphosfonates to Targeted Therapy

Current Medicinal Chemistry, Vol. 19, Iss. 32, 2012-11 ,pp. : 5524-5535

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacokinetic study of the phase III, randomized, double-blind, multicenter trial (TRIBUTE) of paclitaxel and carboplatin combined with erlotinib or placebo in patients with advanced Non-small Cell Lung Cancer (NSCLC)

By Tran Hai Zinner Ralph Blumenschein George Oh Yun Papadimitrakopoulou Vassiliki Kim Edward Lu Charles Malik Mubashira Lum Bert Herbst Roy

Investigational New Drugs, Vol. 29, Iss. 3, 2011-06 ,pp. : 499-505

Springer Publishing Company

Access to resources Recommend Favorite

Non–Small Cell Lung Cancer

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 3, 2008-03 ,pp. : 228-228

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite